Showing results (71-80 of 123) with videos related to
Sort By:
Pageof 13
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 1, 2025
Cancer mortality in Europe in 2020, and an overview of trends since 1990Claudia Santucci, Paola Bertuccio, Silvia Mignozzi, et al.Pediatric Pulmonology|June 13, 2024
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor treatment in children aged 6-11 years with cystic fibrosis in a real-world settingValeria Daccò, Chiara Rosazza, Alessandra Mariani, et al.Lung|November 30, 2024
Lung Clearance Index Improves in People with Cystic Fibrosis not Achieving a Clinical Important Difference in Forced Expiratory Volume in One Second After Elexacaftor/Tezacaftor/Ivacaftor TherapyValeria Daccò, Andrea Gramegna, Chiara Rosazza, et al.Journal of Public Health (Oxford, England)|September 8, 2023
Cancer mortality associated with low education in ItalyMargherita Pizzato, Matteo di Maso, Giulia Collatuzzo, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 25, 2024
A case of severe pulmonary exacerbation in a young patient with cystic fibrosis in the era of CFTR modulatorsChiara Lanfranchi, Carmela Rizza, Maria Chiara Russo, et al.Epidemiologia E Prevenzione|October 30, 2018
[Differences in mortality by educational level in Italy (2012-2014)]Alessio Petrelli, Nicolás Zengarini, Elena Demuru, et al.Endocrine Connections|March 31, 2022
Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosisAlberto Battezzati, Andrea Foppiani, Gianfranco Alicandro, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 7, 2024
Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapyAndrea Gramegna, Massimiliano Ruscica, Gloria Leonardi, et al.European Journal of Clinical Nutrition|February 6, 2024
Legume intake and cancer risk in a network of case-control studiesLinia Patel, Carlo La Vecchia, Eva Negri, et al.Diabetes & Metabolism|August 3, 2023
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetesValeria Grancini, Andrea Gramegna, Laura Zazzeron, et al.Pageof 13